# Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)

> **NCT05329740** · PHASE4 · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 212 (actual)

## Conditions studied

- Methylprednisolone
- Glucocorticoid
- Aortic Dissection
- Organ Dysfunction

## Interventions

- **DRUG:** Methylprednisolone Injection

## Key facts

- **NCT ID:** NCT05329740
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-07
- **Primary completion:** 2023-11-29
- **Final completion:** 2023-11-29
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05329740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05329740, "Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05329740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*